1enz
From Proteopedia
(New page: 200px<br /><applet load="1enz" size="450" color="white" frame="true" align="right" spinBox="true" caption="1enz, resolution 2.7Å" /> '''CRYSTAL STRUCTURE AND...) |
|||
Line 1: | Line 1: | ||
- | [[Image:1enz.gif|left|200px]]<br /><applet load="1enz" size=" | + | [[Image:1enz.gif|left|200px]]<br /><applet load="1enz" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1enz, resolution 2.7Å" /> | caption="1enz, resolution 2.7Å" /> | ||
'''CRYSTAL STRUCTURE AND FUNCTION OF THE ISONIAZID TARGET OF MYCOBACTERIUM TUBERCULOSIS'''<br /> | '''CRYSTAL STRUCTURE AND FUNCTION OF THE ISONIAZID TARGET OF MYCOBACTERIUM TUBERCULOSIS'''<br /> | ||
==Overview== | ==Overview== | ||
- | Resistance to isoniazid in Mycobacterium tuberculosis can be mediated by | + | Resistance to isoniazid in Mycobacterium tuberculosis can be mediated by substitution of alanine for serine 94 in the InhA protein, the drug's primary target. InhA was shown to catalyze the beta-nicotinamide adenine dinucleotide (NADH)-specific reduction of 2-trans-enoyl-acyl carrier protein, an essential step in fatty acid elongation. Kinetic analyses suggested that isoniazid resistance is due to a decreased affinity of the mutant protein for NADH. The three-dimensional structures of wild-type and mutant InhA, refined to 2.2 and 2.7 angstroms, respectively, revealed that drug resistance is directly related to a perturbation in the hydrogen-bonding network that stabilizes NADH binding. |
==About this Structure== | ==About this Structure== | ||
- | 1ENZ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis] with NAD as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | + | 1ENZ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis] with <scene name='pdbligand=NAD:'>NAD</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ENZ OCA]. |
==Reference== | ==Reference== | ||
Line 13: | Line 13: | ||
[[Category: Mycobacterium tuberculosis]] | [[Category: Mycobacterium tuberculosis]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
- | [[Category: Blanchard, J | + | [[Category: Blanchard, J S.]] |
[[Category: Dessen, A.]] | [[Category: Dessen, A.]] | ||
- | [[Category: Jr., W | + | [[Category: Jr., W R.Jacobs.]] |
[[Category: Quemard, A.]] | [[Category: Quemard, A.]] | ||
- | [[Category: Sacchettini, J | + | [[Category: Sacchettini, J C.]] |
- | [[Category: TBSGC, TB | + | [[Category: TBSGC, TB Structural Genomics Consortium.]] |
[[Category: NAD]] | [[Category: NAD]] | ||
[[Category: protein structure initiative]] | [[Category: protein structure initiative]] | ||
Line 26: | Line 26: | ||
[[Category: tbsgc]] | [[Category: tbsgc]] | ||
- | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:29:48 2008'' |
Revision as of 10:29, 21 February 2008
|
CRYSTAL STRUCTURE AND FUNCTION OF THE ISONIAZID TARGET OF MYCOBACTERIUM TUBERCULOSIS
Overview
Resistance to isoniazid in Mycobacterium tuberculosis can be mediated by substitution of alanine for serine 94 in the InhA protein, the drug's primary target. InhA was shown to catalyze the beta-nicotinamide adenine dinucleotide (NADH)-specific reduction of 2-trans-enoyl-acyl carrier protein, an essential step in fatty acid elongation. Kinetic analyses suggested that isoniazid resistance is due to a decreased affinity of the mutant protein for NADH. The three-dimensional structures of wild-type and mutant InhA, refined to 2.2 and 2.7 angstroms, respectively, revealed that drug resistance is directly related to a perturbation in the hydrogen-bonding network that stabilizes NADH binding.
About this Structure
1ENZ is a Single protein structure of sequence from Mycobacterium tuberculosis with as ligand. Full crystallographic information is available from OCA.
Reference
Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis., Dessen A, Quemard A, Blanchard JS, Jacobs WR Jr, Sacchettini JC, Science. 1995 Mar 17;267(5204):1638-41. PMID:7886450
Page seeded by OCA on Thu Feb 21 12:29:48 2008